Biondvax Pharmaceuticals Stock Z Score
BVXVDelisted Stock | USD 1.35 0.03 2.17% |
BiondVax |
BiondVax Pharmaceuticals Company Z Score Analysis
BiondVax Pharmaceuticals' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current BiondVax Pharmaceuticals Z Score | -6.6 |
Most of BiondVax Pharmaceuticals' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BiondVax Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionIn accordance with the company's disclosures, BiondVax Pharmaceuticals has a Z Score of -6.6. This is 197.78% lower than that of the Pharmaceuticals sector and 297.6% lower than that of the Health Care industry. The z score for all United States stocks is 175.69% higher than that of the company.
Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
All Next | Launch Module |
BiondVax Fundamentals
Return On Equity | -56.02 | |||
Return On Asset | -0.31 | |||
Current Valuation | 21.94 M | |||
Shares Outstanding | 3.65 M | |||
Shares Owned By Insiders | 20.01 % | |||
Shares Owned By Institutions | 10.69 % | |||
Number Of Shares Shorted | 4.88 K | |||
Price To Earning | (4.91) X | |||
Price To Book | 7.48 X | |||
EBITDA | (10.5 M) | |||
Net Income | (5.8 M) | |||
Cash And Equivalents | 14.55 M | |||
Cash Per Share | 2.23 X | |||
Total Debt | 21.54 M | |||
Current Ratio | 1.71 X | |||
Book Value Per Share | (1.96) X | |||
Cash Flow From Operations | (7.26 M) | |||
Short Ratio | 0.32 X | |||
Earnings Per Share | (2.35) X | |||
Target Price | 39.0 | |||
Number Of Employees | 33 | |||
Beta | 2.37 | |||
Market Capitalization | 4.97 M | |||
Total Asset | 27.07 M | |||
Retained Earnings | (115.83 M) | |||
Working Capital | 12.03 M | |||
Current Asset | 36.93 M | |||
Current Liabilities | 1.7 M | |||
Z Score | -6.6 | |||
Net Asset | 27.07 M |
About BiondVax Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BiondVax Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiondVax Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BiondVax Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in BiondVax Stock
If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |